176 related articles for article (PubMed ID: 3841726)
21. Serum propylthiouracil concentration in patients with Graves' disease with various clinical course.
Sato K; Mimura H; Kato S; Isozaki O; Tsushima T; Shizume K
Acta Endocrinol (Copenh); 1983 Oct; 104(2):189-94. PubMed ID: 6688911
[TBL] [Abstract][Full Text] [Related]
22. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
Cho YY; Shon HS; Yoon HD
Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
[TBL] [Abstract][Full Text] [Related]
23. Antineutrophil autoantibodies in Graves' disease. Implications of thyrotropin binding to neutrophils.
Weitzman SA; Stossel TP; Harmon DC; Daniels G; Maloof F; Ridgway EC
J Clin Invest; 1985 Jan; 75(1):119-23. PubMed ID: 3838096
[TBL] [Abstract][Full Text] [Related]
24. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
25. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
26. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
[TBL] [Abstract][Full Text] [Related]
27. Propylthiouracil-induced antineutrophil cytoplasm antibody-positive anaphylactoid purpura-like vasculitis--a case report.
Wang LH; Tsai MJ; Tsai WY; Lee JS; Chiang BL
J Formos Med Assoc; 2000 Aug; 99(8):642-5. PubMed ID: 10969508
[TBL] [Abstract][Full Text] [Related]
28. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
29. Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy.
Murji A; Sobel ML; Feig DS; Sermer M
Obstet Gynecol; 2010 Aug; 116 Suppl 2():485-487. PubMed ID: 20664427
[TBL] [Abstract][Full Text] [Related]
30. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
[TBL] [Abstract][Full Text] [Related]
31. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
32. Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety.
Tendler BE; Shoukri K; Malchoff C; MacGillivray D; Duckrow R; Talmadge T; Ramsby GR
Thyroid; 1997 Aug; 7(4):625-9. PubMed ID: 9292953
[TBL] [Abstract][Full Text] [Related]
33. The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil.
Wall JR; Manwar GL; Greenwood DM; Walters BA
J Clin Endocrinol Metab; 1976 Dec; 43(6):1406-9. PubMed ID: 1036744
[TBL] [Abstract][Full Text] [Related]
34. [A case of chronic idiopathic neutropenia with complement-dependent opsonic anti-neutrophil antibody: probable autoimmune neutropenia (author's transl)].
Koyama W; Kategawa Y; Kanayama M; Saito K; Furusawa S
Nihon Naika Gakkai Zasshi; 1981 Jun; 70(6):866-71. PubMed ID: 7288246
[No Abstract] [Full Text] [Related]
35. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune neutropenia.
Boxer LA; Greenberg MS; Boxer GJ; Stossel TP
N Engl J Med; 1975 Oct; 293(15):748-53. PubMed ID: 1172188
[TBL] [Abstract][Full Text] [Related]
38. Propylthiouracil induced anti-neutrophil cytoplasmic antibody-associated vasculitis with bone marrow plasmacytosis and granulocytopenia.
Ozkok A; Salman S; Agan M; Yavuz AS; Yarman S; Boztepe H; Alagol F; Tanakol R
Chin Med J (Engl); 2009 May; 122(9):1112-4. PubMed ID: 19493451
[No Abstract] [Full Text] [Related]
39. The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies.
Harmon DC; Weitzman SA; Stossel TP
Br J Haematol; 1984 Oct; 58(2):209-15. PubMed ID: 6383453
[TBL] [Abstract][Full Text] [Related]
40. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism.
Ochoa-Maya MR; Frates MC; Lee-Parritz A; Seely EW
Thyroid; 1999 Nov; 9(11):1111-4. PubMed ID: 10595460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
